Cas:78554-68-4 4-AMinobenzo-12-crown-4 manufacturer & supplier

Chemical Name:4-AMinobenzo-12-crown-4

CAS.NO:78554-68-4

Synonyms:4-AMinobenzo-12-crown-4

Molecular Formula:C₁₂H₁₈NO₄

Molecular Weight:240.27562

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-AMinobenzo-12-crown-4 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-AMinobenzo-12-crown-4 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-AMinobenzo-12-crown-4 Use and application,4-AMinobenzo-12-crown-4 technical grade,usp/ep/jp grade.

Related News: ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 4-AMinobenzo-12-crown-4 manufacturer The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term. 4-AMinobenzo-12-crown-4 supplier The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data. 4-AMinobenzo-12-crown-4 vendor ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 4-AMinobenzo-12-crown-4 factory The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.